Logo image
Feasibility and value of salivary cortisol sampling to reflect distress in head and neck cancer patients undergoing chemoradiation: A proof-of-concept study
Journal article   Open access   Peer reviewed

Feasibility and value of salivary cortisol sampling to reflect distress in head and neck cancer patients undergoing chemoradiation: A proof-of-concept study

Karishma Chhabria, Mark Bonnen, Joshua Asper and Giselle D Carnaby
International journal of oncology research, Vol.5(2)
01/2022
PMID: 36408337

Metrics

106 Record Views

Abstract

Background: Head and neck cancer (HNC) patients undergoing chemo/radiation (C/RT) commonly experience severe and persistent distress associated with treatment related fear and physical side effects such as xerostomia, dysphagia, and dryness of mouth. Cortisol, a stress sensitive hormone, can be easily measured in saliva to reflect biobehavioral responses to such stressors. Unfortunately, it has not been used in this population due to concerns associated with C/RT related xerostomia. Methods: In a proof-of-concept study, we explored the feasibility of collecting salivary cortisol as a marker of fear and distress in HNC patients. Ten HNC subjects undergoing C/RT provided saliva samples for 3 consecutive days across three timepoints (pre-treatment, 3-weeks and 1-month post-treatment) and completed concurrent depression, anxiety and swallowing related fear measures. Results: Salivary cortisol collection adherence was between 60-80%. It was not impacted by xerostomia. Diurnal cortisol pattern's demonstrated dysregulation at pretreatment in 62%, and flattened aberrant slopes continued at 3-weeks and beyond in 50% of subjects. Conclusions: Our study supports the feasibility and utility of salivary cortisol measurement in HNC patients across the treatment trajectory. Diurnal cortisol measures may be a valuable tool to detect and monitor treatment distress during C/RT in this population.
url
Feasibility and value of salivary cortisol sampling to reflect distress in head and neck cancer patients undergoing chemoradiationView
Published (Version of record)link to article Open

Related links

Details

Logo image